AAV1-FS344 regulatory update

Milo said FDA granted Orphan Drug designation to AAV1-FS344 to treat Becker and Duchenne muscular dystrophy. The adeno-associated virus (AAV) vector encoding follistatin is in a Phase I/II trial for B...